Conclusions
death, acute coronary syndrome, non-ischaemic myocardial injury
MYOCARDIAL INFARCTION, SUBSEQUENT MYOCARDIAL INFARCTION, ACUTE CORONARY SYNDROME
Implementation of a high sensitivity cardiac troponin I assay in the assessment of patients with suspected acute coronary syndrome was associated with a reduced risk of subsequent myocardial infarction or death at five years in those reclassified by the high sensitivity assay. Improvements in outcome were greatest in patients with non-ischaemic myocardial injury, suggesting a broader benefit beyond the identification of myocardial infarction.